Moxifloxacin PF

MOXIFLOXACIN PF- moxifloxacin hydrochloride monohydrate injection, solution
ImprimisRx NJ

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Store at 20° to 25° C (68° to 77° F)

Vial Label
(click image for full-size original)

MOXIFLOXACIN PF
moxifloxacin pf injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70261-511
Route of Administration INTRAOCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE (MOXIFLOXACIN) MOXIFLOXACIN 5 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 8 mg in 1 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70261-511-01 1 mL in 1 VIAL, GLASS None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 01/01/2018
Labeler — ImprimisRx NJ (931390178)
Registrant — ImprimisRx NJ (931390178)
Establishment
Name Address ID/FEI Operations
Imprimis Pharmaceuticals 080431967 manufacture (70261-511)

Revised: 05/2018 ImprimisRx NJ

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.